ATGP0824-100ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP0824-500ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
HY-135794-10mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
HY-135794-100mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
HY-135794-5mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
HY-135794-50mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
HY-135794-1mL
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4] (10mM in DMSO)
|
|
|
|
HY-117407-10mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
HY-117407-100mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
HY-117407-5mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
HY-117407-50mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
HY-117407-1mL
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-112288-10mg
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9]
|
|
Cancer-Kinase/protease
|
|
HY-112288-100mg
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9]
|
|
Cancer-Kinase/protease
|
|
HY-112288-25mg
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9]
|
|
Cancer-Kinase/protease
|
|
HY-112288-5mg
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9]
|
|
Cancer-Kinase/protease
|
|
HY-112288-50mg
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9]
|
|
Cancer-Kinase/protease
|
|
HY-112288-1mL
|
MedChemexpress LLC
|
C188-9 [CAS 432001-19-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-16560-100mg
|
MedChemexpress LLC
|
Camptothecin [CAS 7689-03-4]
|
|
Cancer-programmed cell death
|
|
HY-16560-500mg
|
MedChemexpress LLC
|
Camptothecin [CAS 7689-03-4]
|
|
Cancer-programmed cell death
|
|
HY-16560-1mL
|
MedChemexpress LLC
|
Camptothecin [CAS 7689-03-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-107471-10mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-100mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-25mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-5mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|